SYNTA PHARMACEUTICALS INC (SNTA)
(Delayed Data from NSDQ)
$0.34 USD
+0.07 (26.62%)
Updated Jul 22, 2016 03:59 PM ET
After-Market: $0.34 (%) 6:15 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Madrigal Pharmaceuticals, Inc. [SNTA]
Reports for Purchase
Showing records 1 - 20 ( 140 total )
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage
Provider: Roth Capital Partners, Inc.
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
A Black Hole Swallows a GALAXY; We Were Wrong; Downgrade to Neutral
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Management Meetings and Intriguing Times as Programs Mature
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Madrigal Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
2Q15 Results; Interim Analysis Near; IO Combo Program Receives Focus
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J